Loading clinical trials...
Loading clinical trials...
An Observational Clinical Performance Evaluation Study Testing Residual Specimens of Cerebrospinal Fluid Obtained by Lumbar Puncture From Meningitis/Encephalitis Subjects Using the QIAstat-Dx® Meningitis/Encephalitis Panel
Conditions
Interventions
QIAstat-Dx® Meningitis/Encephalitis (ME) Panel
Locations
1
United Kingdom
Qiagen
Manchester, United Kingdom
Start Date
May 4, 2022
Primary Completion Date
March 2, 2023
Completion Date
March 2, 2023
Last Updated
October 17, 2024
NCT05777499
NCT05092438
NCT04094818
Lead Sponsor
QIAGEN Gaithersburg, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions